Clinical trial Recruiting at 1 site Interventional Ages 18 and up Women only

Group exercise program for women after breast cancer treatment

Official title: Strength After Breast Cancer: Clinical Implementation of an Evidence-based Group Exercise Intervention for Breast Cancer Survivors

Run by MGH Institute of Health Professions · NCT06052488 · Data updated 2026-11-12

This study is testing a group exercise program for women who have finished breast cancer treatment to see if it helps them stay active and feel better.

Quick facts

Study typeInterventional
Ages18 Years and up
SexWomen only
Enrollment40 (estimated)
SponsorMGH Institute of Health Professions
Academic / other
Drugs / interventionschemotherapy, radiation
Locations1 site (Boston, Massachusetts)
StatusRecruiting
StartedJanuary 2, 2024
Main results expectedSeptember 2026
Study endsMarch 2027
Registry record updatedOctober 20, 2025
Trial IDNCT06052488 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are women aged 18 and older who have been diagnosed with Stage I-III breast cancer and have completed their primary cancer treatment.

Probably not a fit

Patients with medical conditions that prevent safe exercise or those who do not speak English may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study aims to evaluate the feasibility of the Strength After Breast Cancer (SABC) program, a group exercise intervention designed for women who have completed treatment for breast cancer. Conducted at Massachusetts General Hospital, participants will undergo a physical therapy evaluation and engage in a four-session exercise program that includes both group and home-based activities. The study will assess the practicality of delivering this program in an outpatient setting and identify barriers and facilitators to its implementation. Participants will complete questionnaires and interviews to provide feedback on their experience and the program's effectiveness.

Why it matters

Potential benefit: If successful, this program could significantly improve physical function and quality of life for women recovering from breast cancer.

How similar studies have gone: Previous studies have shown that similar exercise interventions can improve physical function in breast cancer survivors, indicating a promising approach.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* ≥18 years of age
* Diagnosed with Stage I-III breast cancer, having completed primary cancer treatment (e.g., surgery, chemotherapy, radiation therapy); hormonal therapies and adjuvant targeted therapies will be permitted

Exclusion Criteria:

* Any injury or medical condition that would prohibit being able to safely perform exercise as indicated by the Physical Activity Readiness Questionnaire (i.e., atrial fibrillation, chest pain or angina, uncontrolled high blood pressure or hypertension, loss of balance due to dizziness in the past 12 months, or loss of consciousness in the past 12 months).
* Non-English speaking

Where it's running

  • MGH Institute of Health Professions
    Boston, Massachusetts, United States
    Recruiting

Study contacts

  • Principal investigator: Stephen Wechsler, DPT, PhD — MGH Institute of Health Professions
  • Study coordinator: Stephen Wechsler, DPT, PhD
  • Email: swechsler@mghihp.edu
  • Phone: 774-217-3221

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.